Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases

Curr Med Chem. 2018;25(11):1311-1326. doi: 10.2174/0929867324666170619104105.

Abstract

Background: A defective mucosal barrier function is the principal cause of the uncontrolled onset and progression of a number of human inflammatory gut diseases, most of which are characterized by chronic intermittent immune and inflammatory responses leading to structural intestinal damage, which can represent a potential risk for colorectal cancer development. During the active disease phase the production of pro-inflammatory cytokines and chemokines, and the induction of oxidative reactions by activated leukocytes and epithelial cells represent the main event in the intestinal inflammation.

Objective: Oxidative stress plays a key role in the development of intestinal damage. Indeed reactive oxygen species and their oxidized by-products regulate redox-sensitive signaling pathways and transcription factors, which sustain inflammation within the intestinal layer.

Methods: Polyunsaturated fatty acids and cholesterol are the principal targets of oxidative modifications. These lipids, which are cell membrane constituents or are present in food, readily undergo non-enzymatic oxidation to form chemically-reactive species that can induce a wide range of biological effects including inflammation, programmed cell death, and proliferation.

Results and conclusions: In this review we summarize the current knowledge on the role of lipid oxidation products in regulating redox pathways involved in the pathogenesis of inflammation- related gut diseases. In particular, lipid peroxidation end products, such as isoprostanes and aldehydes, and cholesterol oxidation-derived oxysterols are taken into consideration. The control of oxidative damage and consequently tissue local over-production of lipid oxidation products by using specific antioxidant and anti-inflammatory molecules in the diet may have clinical and therapeutic benefits.

Keywords: 4-hydroxynonenal; Gut; acrolein; intestinal bowel disease; isoprostanes; malondialdehyde; oxysterols; polyphenols..

Publication types

  • Review

MeSH terms

  • Aldehydes / metabolism*
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Inflammation / metabolism
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / etiology*
  • Inflammatory Bowel Diseases / physiopathology
  • Isoprostanes / metabolism*
  • Lipid Peroxidation*
  • Oxidative Stress
  • Oxysterols / metabolism*
  • Reactive Oxygen Species / chemistry
  • Reactive Oxygen Species / metabolism

Substances

  • Aldehydes
  • Gastrointestinal Agents
  • Isoprostanes
  • Oxysterols
  • Reactive Oxygen Species